FDA Commissioner Stephen Hahn said the agency will publicize reviews of all data and relevant information about COVID-19 vaccines and therapeutics granted emergency use authorization in order to boost the public's confidence in the agency's review process. "We will also continue to follow the science and ensure that science remains the driver of the agency's regulatory decision-making in our fight against COVID-19 and beyond on behalf of public health," Hahn said.
FDA: EUA info on COVID-19 vaccines, drugs to be publicized
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.